Want to join the conversation?
Generic pharmaceutical products maker $LCI said it plans to co-develop a generic insulin product for the US market with its Chinese partner, YiChang HEC ChangJiang Pharmaceutical Co., an HEC Group company. $LCI has the exclusive US marketing rights to the product, which is currently in late stage development.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?